DE1207876T1 - Benützung von proteinaseinhibitoren, um die spaltung von wachstumfaktorvorläufern zu verhindern - Google Patents

Benützung von proteinaseinhibitoren, um die spaltung von wachstumfaktorvorläufern zu verhindern

Info

Publication number
DE1207876T1
DE1207876T1 DE1207876T DE00951521T DE1207876T1 DE 1207876 T1 DE1207876 T1 DE 1207876T1 DE 1207876 T DE1207876 T DE 1207876T DE 00951521 T DE00951521 T DE 00951521T DE 1207876 T1 DE1207876 T1 DE 1207876T1
Authority
DE
Germany
Prior art keywords
cutting
prevent
growth factor
protein inhibitors
factor precursors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE1207876T
Other languages
English (en)
Inventor
Axel Ullrich
Norbert Prenzel
Henrik Daub
Esther Zwick-Wallasch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/461,090 external-priority patent/US7632645B1/en
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of DE1207876T1 publication Critical patent/DE1207876T1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE1207876T 1999-08-16 2000-08-16 Benützung von proteinaseinhibitoren, um die spaltung von wachstumfaktorvorläufern zu verhindern Pending DE1207876T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99116056 1999-08-16
US09/461,090 US7632645B1 (en) 1999-08-16 1999-12-14 EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF
PCT/EP2000/008007 WO2001012182A1 (en) 1999-08-16 2000-08-16 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor

Publications (1)

Publication Number Publication Date
DE1207876T1 true DE1207876T1 (de) 2003-01-09

Family

ID=26153086

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1207876T Pending DE1207876T1 (de) 1999-08-16 2000-08-16 Benützung von proteinaseinhibitoren, um die spaltung von wachstumfaktorvorläufern zu verhindern

Country Status (6)

Country Link
EP (2) EP1207876B9 (de)
JP (1) JP2003506489A (de)
AU (1) AU779298B2 (de)
CA (1) CA2380753C (de)
DE (1) DE1207876T1 (de)
WO (1) WO2001012182A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050176633A1 (en) * 2002-03-08 2005-08-11 Axel Ullrich Use of egfr transactivation inhibitors in human cancer
EP1493445A1 (de) * 2003-07-04 2005-01-05 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Inhibierung von Stress-induzierter Liganden-abhängiger EGFR Aktivierung
EP2561759A1 (de) 2011-08-26 2013-02-27 Bayer Cropscience AG Fluoralkyl-substituierte 2-amidobenzimidazole und ihre Wirkung auf das Pflanzenwachstum

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE225343T1 (de) * 1995-12-20 2002-10-15 Hoffmann La Roche Matrix-metalloprotease inhibitoren

Also Published As

Publication number Publication date
JP2003506489A (ja) 2003-02-18
CA2380753C (en) 2013-10-08
WO2001012182A1 (en) 2001-02-22
AU779298B2 (en) 2005-01-13
EP1207876B1 (de) 2011-06-22
CA2380753A1 (en) 2001-02-22
EP1207876A1 (de) 2002-05-29
EP1820500A1 (de) 2007-08-22
AU6442600A (en) 2001-03-13
EP1207876B9 (de) 2012-04-18

Similar Documents

Publication Publication Date Title
ID30460A (id) Inhibitor-inhibitor protein siklik tirosin kinase
DE60026916D1 (de) Beschichtete PCBN-Schneidewerzeuge
DZ3186A1 (fr) Ptéridinones utilisées comme inhibiteurs de kinase.
DE60108754D1 (de) Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum
DE69914465D1 (de) Mehrzweckmesser
ZA200107450B (en) Dimeric compounds and their use as inhibitors of neuraminidase.
NL300242I1 (nl) Mega-carboxyaryl gesubstitueerde difenylureums alsraf kinaseremmers.
MXPA03008485A (es) Derivados espirociclicos nuevos y su uso como inhibidores de fosfodiesterasa-7.
MA26812A1 (fr) Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases
IT1317741B1 (it) Metodo per la preparazione di 5-cianoftalide.
ID28436A (id) Alat pemakai untuk tampon
IT1319251B1 (it) Metodo per la preparazione di 5-carbossiftalide.
NO20016201D0 (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
AU2001277524A1 (en) Novel use of inhibitors of the epidermal growth factor receptor
NO20020156D0 (no) Titanavledede forbindelser, fremstilling og anvendelse derav
ID29339A (id) Alat pengantar obat, khususnya untuk pengantar androgen
ATE250256T1 (de) Verfahren zur präparation von pyrimidonderivaten mit fungizidder aktivität
ITRM990426A0 (it) Impiego di inibitori della sostanza p per il trattamento degli adenocarcinomi.
ATE339438T1 (de) Substanziell kristalline form von melagatran
IT1309312B1 (it) Impianto per la lavorazione di corpi piani.
DE69920224D1 (de) Harnstoffderivate zur Schmerzbekämpfung
DE50009938D1 (de) Verwendung von nanoskaligen wachsen
DE1207876T1 (de) Benützung von proteinaseinhibitoren, um die spaltung von wachstumfaktorvorläufern zu verhindern
IT1308195B1 (it) Utensile per la troncatura di arbusti.
FR2815332B1 (fr) Devidoir suspendu, notamment pour cultures